Clinical Trials

Study Title:
Randomized, Phase III Study of Early Intervention With Venetoclax and Obinutuzumab Versus Delayed Therapy With Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study

For more information about the trial above please contact the study team:

Medical University of South Carolina
Affiliate Principal Investigator, Lupak, Oleksandra, at lupak@musc.edu.
Principal Investigator, Hess, Brian, at hessbr@musc.edu.
Study Coordinator, Smith, Julia, at smijuli1@musc.edu.

Ralph H. Johnson VAMC
Study Coordinator, Jeter, Kathy, at katherine.jeter2@va.gov.

Trial opened at the following institutions: Ralph H. Johnson VAMC, Medical University of South Carolina